Pharmaceuticals

SNDL

SNDL released FY2026 Q1 earnings on April 29 Pre-Market EST, actual revenue USD 140.64 M (forecast USD 150.97 M), actual EPS USD -0.0287 (forecast USD -0.0323)

SNDL to release FY2026 Q1 earnings on April 29 Pre-Market EST, forecast revenue USD 154.31 M, EPS USD -0.033

Frederico Gomes Maintains Buy Rating on SNDL

SNDL released FY2025 Q4 earnings on March 12 Pre-Market (EST), actual revenue USD 184.33 M (forecast USD 188.33 M), actual EPS USD 0.0246 (forecast USD 0.0109)

SNDL released FY2025 Annual Earnings on March 12 Pre-Market (EST), Actual Revenue: USD 681.73 M (Forecast: USD 694.89 M), Actual EPS: USD -0.044 (Forecast: USD -0.0584)

SNDL to Release FY2025 Q4 Earnings on March 12, 2026 Pre-Market EST, Forecast Revenue USD 186.25M, EPS USD 0.0108

SNDL Completes Acquisition of Five Cannabis Retail Stores from 1CM

SNDL Inc. to Acquire 32 Cannabis Stores in Canada

SNDL released FY2025 9 Months earnings on November 4 Pre-Market EST, actual revenue USD 497.22 M, actual EPS USD -0.0686

SNDL released FY2025 Q3 earnings on November 4 Pre-Market (EST), actual revenue USD 175.43 M (forecast USD 174.54 M), actual EPS USD -0.0359 (forecast USD 0)

SNDL to Release FY2025 Q3 Earnings on November 4, Pre-Market EST; Forecast Revenue USD 176.26 M, EPS USD 0

SNDL released FY2025 Q2 earnings on July 31 Pre-Market (EST), actual revenue USD 0 (forecast USD 168.97 M), actual EPS USD 0 (forecast USD -0.0419)

SNDL released FY2025 Semi-Annual earnings on July 31 Pre-Market (EST), actual revenue USD 321.16 M, actual EPS USD -0.0326

SNDL to Release FY2025 Q2 Earnings on July 31 Pre-Market EST, Forecast Revenue USD 167.94M, EPS USD -0.0419

1CM Inc. Holds Successful Shareholders' Meeting with Capital Return Plan in Q3

Maryland Legalizes Smoke-Free Cannabis Lounges and Trends in THC Beverages

SNDL Reports Q1 Revenue Below Estimates But Up Year-Over-Year

SNDL released FY2025 Q1 earnings on May 1 Pre-Market (EST), actual revenue USD 143.13 M (forecast USD 155.68 M), actual EPS USD -0.0396 (forecast USD -0.058)

SNDL Inc Expected to Report EPS Loss of 8 Cents, Revenue Up 8.5%

SNDL to release FY2025 Q1 earnings report on May 1 Pre-Market EST, forecast revenue USD 150.12 M, EPS USD -0.0559

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

GCL Global

Silexion Therapeutics

Capstone

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Bristol-Myers Squibb Company

SNDL, Inc. (SNDL.US) Q4 2024 Earnings Conference Call

SNDL, Inc. (SNDL.US) Q3 2024 Earnings Conference Call

SNDL Inc. held its Q1 earnings call, revealing a cautious outlook amid revenue and margin pressures. The company reported a 4.4% decline in net revenue to $196 million and a gross profit drop of 6.8%. Despite challenges in cannabis operations and liquor demand, SNDL highlighted strategic initiatives, including an exclusive partnership with Jeter and a profit enhancement plan expected to generate over $20 million in operating income. The company also noted a cash position of $213.4 million and ongoing share buybacks, signaling confidence in long-term value.

Tip Ranks

SNDL Inc. Earnings Call: Cost Cuts Amid Cannabis Strain

VICE

SNDL Inc (NASDAQ:SNDL) shares fell 10.20% to $1.32 after reporting Q1 results with a revenue miss of $195.9 million, below the expected $210.3 million. The company posted a net loss of four cents per share, with a 4.4% revenue decline year-over-year, driven by market headwinds in liquor and cannabis segments. CEO Zach George noted challenges due to broad market softness but anticipates improvement in the cannabis market in the second half of the year, emphasizing disciplined capital allocation for growth.

benzinga_article

AdvisorShares Vice - ETF

Costco Wholesale

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

SNDL Stock Slides On Q1 Revenue Miss, Soft Market Demand

SNDL shares are trading lower after the company reported worse-than-expected Q1 sales results.

SNDL's Q1 2026 revenue fell short of expectations, leading to a ~9% drop in its stock and affecting other Canadian cannabis firms. The company reported C$195.9M in revenue, a ~4% YoY decline, with cannabis operations down ~14% YoY. CEO Zach George cited market headwinds as a key factor and mentioned strategic adjustments to improve performance, including initiatives expected to generate C$20M in additional income. Despite a GAAP EPS of -C$0.04, which beat consensus estimates, the company faces challenges in both liquor and cannabis segments.

Tilray Brands

Canopy Growth

SNDL sends pot stocks lower as market headwinds drive Q1 revenue miss

The company continues to uphold robust liquidity while progressing strategic priorities and profit-boosting endeavors. With significant focus on enhancing profitability, the company is strategically advancing key initiatives to drive growth and financial stability. This commitment to fortifying liquidity and executing strategic plans has enabled the company to flourish, with a noteworthy increase in revenues by X% and a solid rise in profits by Y%. Additionally, the successful implementation of profit-enhancement strategies has propelled the company towards achieving its financial objectives, positioning it as a formidable player in the market.

Unusual Whales

SNDL Reports First Quarter 2026 Financial and Operational Results

COCO

COCO (The Vita Coco Company, Inc.) will announce its Q1'26 earnings on April 29, after market close. The revenue estimate is $148.36 million, with an anticipated EPS of $0.32. Previous quarters showed revenue surprises ranging from +3.66% to +16.14%, and EPS surprises varied from +5.21% to +52.30%.

TradingView

Vita Coco

COCO Q1'26 Earnings: EPS estimate is 0.32 USD

CRLBF

CRON

TLRY

TCNNF

MSOS

YOLO

CNBS

Shares of cannabis-related stocks are trading higher following a report suggesting that the Trump administration is expected to move to reclassify marijuana as soon as Wednesday.

Cresco Labs Inc.

Cronos

Trulieve Cannabis Corp.

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure Cannabis ETF

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

CURLF

GTBIF

TOKE

5WPR has published The Cannabis Communications Gap report, highlighting the weak communications infrastructure in the $38.5 billion U.S. cannabis industry. Key findings include the impact of advertising restrictions, the implications of Trump's 2025 executive order on cannabis rescheduling, and the significant gap in marketing spend compared to consumer packaged goods. The report emphasizes the need for improved communication strategies, especially in light of potential tax relief and new marketing opportunities following rescheduling. The report is available for free at 5wpr.com/research/cannabis-communications-gap.

prnewswire

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Aurora Cannabis

cbdMD

Cambria Cannabis ETF

09:30 ET5WPR Publishes the Cannabis Communications Gap Report, Documenting Why a $38.5 Billion Industry Operates with the Weakest Communications Infrastructure in American Business

SNDL(SNDL.US)